Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody

Bähr-Mahmud, H; Ellinghaus, U; Stadler, CR; Fischer, L; Lindemann, C; Chaturvedi, A; Diekmann, J; Woell, S; Biermann, I; Hebich, B; Scharf, C; Siefke, M; Roth, AS; Rao, MR; Brettschneider, K; Ewen, EM; Sahin, U; Türeci, O

Sahin, U (通讯作者),BioNTech SE, Goldgrube 12, D-55131 Mainz, Germany.

ONCOIMMUNOLOGY, 2023; 12 (1):

Abstract

IMAB362/Zolbetuximab, a first-in- class IgG1 antibody directed against the cancer-associated gastric-lineage marker CLDN18.2, has recently been report......

Full Text Link